Dates: 01/01/2020
31/12/2024
Topic: Biomarkers identification
Project type: Preclinic
Clinic
Immunotherapy
Project target: Infectious disease
Financing:
H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being
H2020-EU.3.1.3. – Treating and managing disease
Other
Participating agents:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Keywords: hepatitis B; vaccine; CHB; biomarker; clinical trial; public health; immunology; virus mutation
Countries: France; Switzerland; Sweden; Italy; Germany; Greece; Spain; USA; Belgium
Project page: Access page
